Purdue University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
38
About the Report
About the Report
Summary
Purdue University (Purdue) is an academic and research institution that offers undergraduate, post graduate, honors and research programs. The institution provides off-campus academic programs such as distance learning, zip trips, youth programs and opportunities to study abroad. It offers undergraduate courses in the fields of accounting, agriculture, education, engineering, animation, anthropology, health sciences, liberal arts, polytechnic, exploratory studies and management, among others. Purdue conducts research in the areas of information technology, manufacturing, healthcare, life sciences, information technology, hospitality and financial services, among others. The university works in partnership with various research centers, institutes and companies. Purdue is headquartered in West Lafayette, Indiana, the US.
Purdue University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Purdue University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue University, Medical Devices Deals, 2012 to YTD 2018 9
Purdue University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Purdue University, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11
Venture Financing 12
Symic Biomedical Raises USD15 Million in Series A Financing 12
Partnerships 13
Eli Lilly and Purdue University Enter into Research Agreement 13
Purdue University Enters into MoU with Dr Reddy's Labs 14
Licensing Agreements 15
Cantabio Pharma Enters into Licensing Agreement with Purdue Research Foundation 15
Akanocure Pharma Enters into Licensing Agreement with Purdue Research Foundation 16
Neuro Vigor Enters into Licensing Agreement with Purdue Research Foundation 17
Linus Oncology Enters into Licensing Agreement with Purdue University 18
Aldrich Chemical Enters Into Licensing Agreement With Purdue Research Foundation And Purdue Office of Technology Commercialization 19
Purdue University-Key Competitors 20
Purdue University-Key Employees 21
Purdue University-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Government and Public Interest 24
Sep 18, 2018: USD 1.7 million SBIR grant fast-tracks faster bone fracture healing 24
Aug 21, 2018: New type 1 diabetes therapy shows promise for long-term reversal in both humans, dogs 26
Jun 15, 2018: New compound shown to be as effective as FDA-approved drugs against life-threatening infections; tests indicate it is less susceptible to resistance 28
Apr 12, 2018: Microscopic oxygen bubbles could help improve cancer therapeutics and accelerate wound healing 29
Aug 10, 2017: TSRL Awarded Two NIH Grants to Develop Therapeutics for Multi-Drug Resistant Infections 30
Mar 28, 2017: An old drug with new potential: WWII chemical-weapon antidote shows early promise as treatment for spinal cord injuries 31
Product News 32
Aug 01, 2018: Purdue researchers develop tornado lab-on-a-chip technology with micro tweezers to detect dangerous viruses, biological contaminants 32
Feb 20, 2018: Purdue targeted drug combination could expedite bone fracture healing, be used as injection 33
Other Significant Developments 35
Jul 24, 2018: New 3D, curved technology provides hope for patients and doctors battling some of the most devastating types of cancer 35
Jun 08, 2018: Gene editing just got easier 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Figure
List of Figures
Purdue University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Purdue University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue University, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Purdue University, Pharmaceuticals & Healthcare, Key Facts 2
Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue University, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue University, Medical Devices Deals, 2012 to YTD 2018 9
Purdue University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11
Symic Biomedical Raises USD15 Million in Series A Financing 12
Eli Lilly and Purdue University Enter into Research Agreement 13
Purdue University Enters into MoU with Dr Reddy's Labs 14
Cantabio Pharma Enters into Licensing Agreement with Purdue Research Foundation 15
Akanocure Pharma Enters into Licensing Agreement with Purdue Research Foundation 16
Neuro Vigor Enters into Licensing Agreement with Purdue Research Foundation 17
Linus Oncology Enters into Licensing Agreement with Purdue University 18
Aldrich Chemical Enters Into Licensing Agreement With Purdue Research Foundation And Purdue Office of Technology Commercialization 19
Purdue University, Key Competitors 20
Purdue University, Key Employees 21
Purdue University, Other Locations 22
Purdue University, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.